Diabetes Care

• 

  Publication Venue For

  • Professional Practice Committee: Standards of Medical Care in Diabetes—2020.  43:S3-S3. 2020
  • Professional Practice Committee: Standards of Medical Care in Diabetes—2019.  42:S3-S3. 2019
  • Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401-1408..  41:e90-e91. 2018
  • Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. 2017
  • Diabetes care: Lagniappe and seeing is believing!.  39:1069-1071. 2016
  • Cardiovascular and Other Outcomes Postintervention With Insulin Glargine and Omega-3 Fatty Acids (ORIGINALE)..  39:709-716. 2016
  • Expanding Treatment Options for Youth With Type 2 Diabetes: Current Problems and Proposed Solutions.  39:323-329. 2016
  • Could the discrepancy in perceived emotional care received and provided be a barrier to active diabetes selfmanagement? Insights from the second diabetes attitudes, wishes and needs (DAWN2) study.  39:e20-e21. 2016
  • Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia..  39:300-307. 2016
  • Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association..  38:1777-1803. 2015
  • Patient-reported outcomes and continuous glucose monitoring: Can we do better with artificial pancreas devices?.  38:e70. 2015
  • HARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin..  37:2141-2148. 2014
  • Association of glomerular filtration rate with outcomes of acute stroke in type 2 diabetic patients: results from the China National Stroke Registry..  37:173-179. 2014
  • Determinants of weight gain in the action to control cardiovascular risk in diabetes trial..  36:2162-2168. 2013
  • Exercise training and quality of life in individuals with type 2 diabetes: a randomized controlled trial..  36:1884-1890. 2013
  • Remogliflozin Etabonate, a Selective Inhibitor of the Sodium-Glucose Transporter 2, Improves Serum Glucose Profiles in Type 1 Diabetes.  35:2198-2200. 2012
  • Macronutrients, food groups, and eating patterns in the management of diabetes: A systematic review of the literature, 2010 (Diabetes Care (2012) 35, (434-445)).  35:1395. 2012
  • Response to comment on: Wheeler et al. Macronutrients, food groups, and eating patterns in the management of diabetes: A systematic review of the literature, 2010. Diabetes Care 2012;35:434-445.  35. 2012
  • The impact of frequent and unrecognized hypoglycemia on mortality in the ACCORD study..  35:409-414. 2012
  • Glycemic thresholds for diabetes-specific retinopathy: Implications for diagnostic criteria for diabetes (Diabetes Care (2011) 34, (145-150)).  34:1888. 2011
  • Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: A meta-analysis of 14 cohort studies (Diabetes Care (2010) 33 (2684-2691)).  34:785-786. 2011
  • The association between maternal glucose concentration and child BMI at age 3 years..  34:480-484. 2011
  • Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis..  32:2307-2313. 2009
  • Retinal vascular fractal dimension and risk of early diabetic retinopathy: A prospective study of children and adolescents with type 1 diabetes..  32:2081-2083. 2009
  • Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes (vol 30, pg 1979, 2007).  31:1713-1714. 2008
  • Erratum: For the Sitagliptin 036 Study Group: Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes (Diabetes Care (2007) 30 (1979-1987)).  31:1713. 2008
  • Resting heart rate in middle age and diabetes development in older age..  31:335-339. 2008
  • Erratum: Diabetic retinopathy and the risk of coronary heart disease: The Atherosclerosis Risk in Communities Study (Diabetes Care (2007) 30, (1742-1746)).  30:2762. 2007
  • Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes..  30:1979-1987. 2007
  • Pharmacotherapy of childhood obesity: an evidence-based, conceptual approach..  30:395-402. 2007
  • Impact of a managed-Medicare physical activity benefit on health care utilization and costs in older adults with diabetes..  30:43-48. 2007
  • Continuous glucose monitoring-guided insulin adjustment in children and adolescents on near-physiological insulin regimens: a randomized controlled trial..  29:1512-1517. 2006
  • High-risk individuals' willingness to pay for diabetes risk-reduction programs..  29:1351-1356. 2006
  • Is peripheral neuropathy associated with retinopathy and albuminuria in individuals with impaired glucose metabolism? The 1999-2000 AusDiab..  29:1114-1116. 2006
  • Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression..  29:265-270. 2006
  • Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes..  29:9-14. 2006
  • Risking health to avoid injections: preferences of Canadians with type 2 diabetes..  28:2243-2245. 2005
  • Fiber and C-reactive protein in diabetes, hypertension, and obesity..  28:1487-1489. 2005
  • Early pregnancy insulin resistance and subsequent gestational diabetes mellitus..  28:1207-1208. 2005
  • Effectiveness of diabetic therapeutic footwear in preventing reulceration: response to Maciejewski et al..  27:3024-3025. 2004
  • Caffeine impairs glucose metabolism in type 2 diabetes..  27:2047-2048. 2004
  • Effectiveness of diabetic therapeutic footwear in preventing reulceration..  27:1774-1782. 2004
  • Diabetes-related utilization and costs for inpatient and outpatient services in the Veterans Administration..  27 Suppl 2:B69-B73. 2004
  • The effect of the PREMIER interventions on insulin sensitivity..  27:340-347. 2004
  • Inflammation and glucose intolerance: a prospective study of gestational diabetes mellitus..  27:21-27. 2004
  • Screening for celiac disease in children with type 1 diabetes: two views of the controversy..  26:1932-1939. 2003
  • Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans..  26:791-798. 2003
  • First-trimester C-reactive protein and subsequent gestational diabetes..  26:819-824. 2003
  • Prevalence and costs of major depression among elderly claimants with diabetes..  26:415-420. 2003
  • Quality of care for patients diagnosed with diabetes at screening..  26:367-371. 2003
  • Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III..  26:468-470. 2003
  • Weight control practices and disordered eating behaviors among adolescent females and males with type 1 diabetes: associations with sociodemographics, weight concerns, familial factors, and metabolic outcomes..  25:1289-1296. 2002
  • Impact of diabetes screening on quality of life..  25:1022-1026. 2002
  • Hostility, race, and glucose metabolism in nondiabetic individuals..  25:835-839. 2002
  • Stress management improves long-term glycemic control in type 2 diabetes..  25:30-34. 2002
  • Rate and predictors of glycemic testing of nondiabetic patients in a managed care population..  24:957-959. 2001
  • Behavioral science research in diabetes: lifestyle changes related to obesity, eating behavior, and physical activity..  24:117-123. 2001
  • Glycemic control and impaired autonomic function: Is glucose the sole culprit? [11].  23:1863-1864. 2000
  • Personality correlates of glycemic control in type 2 diabetes..  23:1321-1325. 2000
  • Novel hepatoselective insulin analog: studies with a covalently linked thyroxyl-insulin complex in humans.  23:1124-1129. 2000
  • Is there a glycemic threshold for impaired autonomic control?.  23:826-830. 2000
  • The family and disease management in Hispanic and European-American patients with type 2 diabetes..  23:267-272. 2000
  • Determining an episode of care using claims data. Diabetic foot ulcer..  22:1110-1115. 1999
  • Oral agent therapy in the treatment of type 2 diabetes..  22 Suppl 3:C61-C64. 1999
  • Efficacy and safety of acarbose in metformin-treated patients with type 2 diabetes..  21:2050-2055. 1998
  • Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study..  21:949-958. 1998
  • Prevalences of type 2 diabetes, the insulin resistance syndrome, and coronary heart disease in an elderly, biethnic population..  21:959-966. 1998
  • Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points..  21:655-657. 1998
  • Physical activity and NIDDM in African-Americans. The Pitt County Study..  21:555-562. 1998
  • Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes..  20:1539-1542. 1997
  • Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group..  20:597-606. 1997
  • Solitary pancreas transplantation. Experience with 62 consecutive cases..  20:362-368. 1997
  • Major depressive disorder in youths with IDDM. A controlled prospective study of course and outcome..  20:45-51. 1997
  • Psychiatric disorders in youths with IDDM: rates and risk factors..  20:36-44. 1997
  • Clinical and radiographic findings that lead to intervention in diabetic patients with foot ulcers. A nationwide survey of primary care physicians..  19:755-757. 1996
  • Magnesium supplementation in the treatment of diabetes.  19. 1996
  • Magnesium supplementation in the treatment of diabetes.  18:83-85. 1995
  • Lipoprotein(a) and silent myocardial ischemia in IDDM..  17:1365-1367. 1994
  • A telephone-delivered intervention for patients with NIDDM. Effect on coronary risk factors..  17:840-846. 1994
  • Relaxation training for NIDDM. Predicting who may benefit..  16:1087-1094. 1993
  • Pancreas transplantation for patients with diabetes mellitus. American Diabetes Association..  15:1673. 1992
  • Pancreas transplantation for patients with diabetes mellitus. American Diabetes Association..  15:1668-1672. 1992
  • Screening for microalbuminuria. A comparison of single sample methods of collection and techniques of albumin analysis..  15:1581-1584. 1992
  • Stress and diabetes mellitus..  15:1413-1422. 1992
  • Magnesium supplementation in the treatment of diabetes. American Diabetes Association..  15:1065-1067. 1992
  • Do you really get a diet soft drink when you order one?.  15:933-934. 1992
  • Microangiopathic ischemic myopathy of semimembranosus muscle in patient with diabetes mellitus..  15:586-587. 1992
  • Plasma levels of beta-endorphin and adrenocorticotropic hormone in IDDM and NIDDM..  15:590-591. 1992
  • Do you really get a diet soft drink when you order one? [3].  15:940-941. 1992
  • Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetes mellitus. Randomized controlled trial comparing blood and urine testing..  13:1044-1050. 1990
  • Family functioning and metabolic control of school-aged children with IDDM..  12:409-414. 1989
  • Accuracy of nurses in performing capillary blood glucose monitoring..  12:298-301. 1989
  • Psychological predictors of glucose control in patients with IDDM..  11:798-800. 1988
  • Prevalence of asymptomatic bacteriuria in subjects with NIDDM in San Luis Valley of Colorado..  11:708-712. 1988
  • Type A behavior pattern and chronic glycemic control in individuals with IDDM..  11:361-362. 1988
  • Stress and autonomic nervous system in type II diabetes. A hypothesis..  11:83-85. 1988
  • Relaxation Therapy: A Reply.  10:794-795. 1987
  • Cognitive Functioning and Diabetes: A Reply.  10:136-137. 1987
  • Effects of relaxation therapy on patients with type I diabetes mellitus..  10:72-75. 1987
  • Differential glycemic response to stress in type A and type B individuals with IDDM..  9:550-552. 1986
  • Accommodating Planned Exercise in Type I Diabetic Patients on Intensive Treatment.  8:337-342. 1985
  • Metabolic Response to Fasting Exercise in Adolescent Insulin-Dependent Diabetic Subjects Treated with Continuous Subcutaneous Insulin Infusion and Intensive Conventional Therapy.  7:255-260. 1984
  • Relaxation-induced improvement in glucose tolerance is associated with decreased plasma cortisol..  7:203-204. 1984
  • Accuracy of two systems for blood glucose monitoring without a meter (Chemstrip/Visidex)..  6:533-535. 1983
  • The effects of relaxations on glucose tolerance in non-insulin-dependent diabetes..  6:176-179. 1983
  • Porcine and human insulin (Novo): a comparison of their metabolism and hypoglycemic activity in normal man..  6 Suppl 1:9-12. 1983
  • A Double-Blind Crossover Trial Comparing Human Insulin (recombinant DNA) with Animal Insulins in the Treatment of Previously Insulin-treated Diabetic Patients.  5:129-134. 1982
  • Induced basal normoglycemia and altered platelet aggregation in non-insulin-dependent diabetes..  5:433-437. 1982
  • The role of behavior in diabetes care..  5:337-342. 1982
  • Myocardial infarction site and mortality in diabetes..  5:31-35. 1982
  • An algebra for adiposity?.  4:328-329. 1981
  • For Reading on Writing.  3:198-198. 1980
  • Immunologic reactions to insulin..  3:204. 1980
  • Cheiralgia paresthetica in diabetes mellitus..  1:365-366. 1978
  • Sulfonylurea drugs: mechanism of antidiabetic action and therapeutic usefulness..  1:189-198. 1978